Breaking the silence: Exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises

Value in Health

Volumn 12, Issue 1, 2009, Pages 172-180

  Krol, Marieke ^a,c   Sendi, Pedram ^b   Brouwer, Werner ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Office L3 081   (Netherlands)

Author keywords

Health state valuations; Leisure time; Productivity costs; Time trade off

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXERCISE; FEMALE; HEALTH CARE COST; HUMAN; LEISURE; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT;

ACTIVITIES OF DAILY LIVING; ADULT; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; INCOME; LEISURE ACTIVITIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 58849129190     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00406.x     Document Type: Article

References (23)

1. Brouwer WBF, van Exel NJ, Baltussen RMPM, Rutten FFH. A dollar is a dollar - or is it? Value Health 2006 9 : 341 7.
2. Sculpher M. The role and estimation of productivity costs in economic evaluation. In : Drummond MF, McGuire A, eds. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford : Oxford University Press, 2001.
3. Olsen J, Richardson J. Production gains from health care: what should be included in cost-effectiveness analysis. Soc Sci Med 1999 49 : 17 26.
4. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995 14 : 171 89.
5. Rothermich EA, Pathak DS. Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. Clin Ther 1999 21 : 255 67.
6. Drummond MF. Methods for the Economic Evaluation of Health Care Programmes (3rd ed.). Oxford medical publications. Oxford; New York : Oxford University Press, 2005.
7. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ 1997 6 : 511 4.
8. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ 1997 6 : 253 9.
9. Brouwer WBF, Rutten FFH. The missing link: on the line between C and E. Health Econ 2003 12 : 629 36.
10. Gold M, Siegel J, Russell L, et al. Cost-Effectiveness in Health and Medicine. Oxford : Oxford University Press, 1996.
11. Meltzer D, Johannesson M. Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine. Med Decis Making 1999 19 : 371 7.
12. Johannesson M. Avoiding double-counting in pharmacoeconomic studies. Pharmacoeconomics 1997 11 : 385 8.
13. Sculpher MJ, O'Brien BJ. Income effects of reduced health and health effects of reduced income: implications for health-state valuation. Med Decis Making 2000 20 : 207 15.
14. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ 1986 5 : 1 30.
15. Sendi P, Brouwer WBF. Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health Econ 2005 14 : 643 7.
16. Meltzer D, Weckerle C, Chang L. Do people consider financial effects in answering quality of life questions? Med Decis Making 1999 19 : 517.
17. Krol M, Brouwer W, Sendi P. Productivity costs in health-state valuations: does explicit instruction matter? Pharmacoeconomics 2006 24 : 401 14.
18. Brouwer WBF, Grootenboer S, Sendi P. The sound of silence: income and leisure in health state valuations. Working paper, Erasmus University Rotterdam 2008.
19. Parkin D, Devlin M. Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ 2006 15 : 653 64.
20. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997 35 : 1095 108.
21. Lamers LM, McDonnell J, Stalmeier PF, et al. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006 15 : 1121 32.
22. Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making 2001 21 : 329 34.
23. Arnesen T, Trommald M. Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method. J Health Serv Res Policy 2004 9 : 43 50.